November 2009

 

In this Supplement

Carotid Embolic Protection

An in-depth look at the current state of cerebral protection and the evolving role of today's option including the GORE Flow Reversal System.

Issue

Supplement

Download a PDF of this supplement

The State of Carotid Embolic Protection and the Role of Flow Reversal

A panel of carotid stenting experts engages in a candid discussion of data, devices, decisions, and the future of embolic protection in carotid stenting procedures.

Microembolization: The Achilles’ Heel of CAS?

The incidence of procedural microembolization may depend on the type of EPD employed.

By Sumaira Macdonald, MBCHB, FRCP, FRCR, PhD; Barry T. Katzen, MD, FACC, FACR, FSIR; AND Claudio Schönholz, MD

The Albany Vascular Group Experience

Embolic protection during carotid artery stenting using the GORE Flow Reversal System.

By MANISH MEHTA, MD, MPH; JOHN B. TAGGERT, MD; YARON STERNBACH, MD; PAUL B. KREIENBERG, MD; SEAN P. RODDY, MD; PHILIP S.K. PATY, MD; KATHLEEN J. OZSVATH, MD; BENJAMIN B. CHANG, MD; DHIRAJ M. SHAH, MD; AND R. CLEMENT DARLING III, MD

The Emory Experience

A review of carotid stenting, flow reversal, microembolization, and vascular dementia.

By KARTHIKESHWAR KASIRAJAN, MD, AND LUKE BREWSTER, MD

Stroke Prevention in Carotid Artery Stenting

Gary Ansel, MD, discusses the goals and challenges of embolic protection, the potential of flow reversal, and how stroke rates have improved over the past decade.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.